CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
The ZELTIQ Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04506502
NCT04506502N/ACompleted

Functional Changes With Magnetic Muscle Stimulation of Abdominal Muscle

Zeltiq Aesthetics·interventional·Posted Aug 10, 2020·Updated May 16, 2025

In Brief

A clinical study evaluating The ZELTIQ System for Muscle Weakness. Completed, enrolled 16 participants across 1 site.

Detailed Summary

Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Weakness
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 10, 2020
Enrollment StartMar 4, 2020
Primary CompletionMay 18, 2021
Study CompletionJul 6, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.9 years ago

Interventions

The ZELTIQ Systemdevice

The MMS device will be used to perform the treatments.